Health Care Facilities

CONCORD HC GP

CONCORD HC GP released FY2025 9 Months Earnings on March 27, 2026 (BJT), with actual revenue of HKD 359.1 M and EPS of HKD -0.3213

CONCORD HC GP released FY2025 Q3 earnings on March 27, 2026 (BJT) with actual revenue of HKD 141.58 M and EPS of HKD -0.0564

CONCORD HC GP released FY2025 Q4 earnings on March 27 During-Market (BJT), actual revenue HKD 144.02 M, actual EPS HKD -0.0574

CONCORD HC GP released FY2025 earnings on March 27 During-Market BJT, actual revenue HKD 502.68 M, actual EPS HKD -0.3749

CONCORD HC GP to Release FY2025 Earnings Report on March 27 During-Market BJT

Meizhongjiaha Hezi's Subsidiary Guangzhou Taihe Tumor Hospital Approved to Join the Guangdong-Hong Kong-Macao Greater Bay Area Pilot Program

AIA Hong Kong and Mainland China Establish Strategic Partnership with China-US Hi-Tech for Proton Therapy

Concord Medical Plans to Increase Holdings in Meizhong Jiaheng

Meizhongjiaheng Successfully Developed Intelligent Health Check Report System

CONCORD HC GP released FY2025 Q1 earnings on August 28, 2025 (BJT) with actual revenue of HKD 107.58 M and EPS of HKD -0.131

CONCORD HC GP released FY2025 Semi-Annual earnings on August 28 During-Market (BJT), actual revenue HKD 217.53 M, actual EPS HKD -0.2648

CONCORD HC GP released FY2025 Q2 earnings on August 28 During-Market (BJT), actual revenue HKD 109.95 M, actual EPS HKD -0.1313

CONCORD HC GP to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

Medi-Cancer Care Completes Placement of 48.7236 Million Shares

Medi-C Global Raises HKD 259M Through Placing

Guangzhou Taihe Tumor Hospital Completes First Proton Therapy for Choroidal Melanoma

Meizhongjiaheng Announces Changes in Shanghai Xinhe Partners

Controlling Shareholder of China MediTech Sells 4.46% Shares for 200 Million Yuan

Medi-Care Plus Issuing 18.6 Million New H Shares

Medisonica Releases Proton Therapy Large Language Model

I.CENTURY HLDG

RIVERINE CHINA

KOS TALENT GP

CHINA CBS INTL

NATURE ENERGY T

DIGIT HOLLYWOOD

REDCO HEALTHY

ZXZN QI-HOUSE

ASIA PIONEER

HUISHENG INTL

02453

Concord Healthcare Group Co., Ltd. has successfully completed a HK$68 million convertible bond issue under its general mandate. The bonds, convertible into H shares at an initial price of HK$1.70, will provide additional capital while adhering to existing shareholder authorization. The company controls potential adjustments to the conversion price and does not anticipate exceeding the current mandate limit. A full bond conversion could increase total share capital to 823,662,016 shares, resulting in a modest dilution for existing shareholders. Concord Healthcare operates in the medical and healthcare services sector in China and is listed in Hong Kong.

Tip Ranks

Concord Healthcare Completes HK$68 Million Convertible Bond Issue Under General Mandate

Concord Healthcare Group plans to raise HK$68 million through convertible bonds to repay debts and enhance working capital. The bonds will have an initial conversion price of HK$1.70 per share, with net proceeds estimated at HK$63.1 million. Approximately 70% of the funds will be allocated for loan repayment, while 30% will support working capital. The company will seek listing approval for the conversion shares, and the transaction is subject to conditions. Concord Healthcare operates in the healthcare sector and is listed in Hong Kong under stock code 2453.

Concord Healthcare to Raise HK$68 Million via Convertible Bonds for Debt Repayment and Working Capital

516610

CONCORD HC GP announced its full-year results for the year ended December last year, with a revenue of RMB 460 million, an increase of 18.4% year-on-year. The loss narrowed to RMB 257 million, compared to a loss of RMB 443 million in the same period last year; the loss per share was RMB 0.34. No dividend was declared

AASTOCKS

Dacheng CSI All Share Health Care Equipment and Services ETF

"Performance" CONCORD HC GP's annual loss narrowed to 257 million RMB

562600

159883

Concord Healthcare Narrows Losses as Revenue Climbs and Gross Margin Turns Positive

ChinaAMC CSI All Share Health Care Devices ETF

Maxwealth CSI All Share Medical Apparatus and Instruments ETF

iShares Global Healthcare

VG Health

Health Care Select Sector SPDR

Concord Medical

iShares US Healthcare Providers

SPDR S&P Health

Concord Healthcare Narrows Losses as Revenue Climbs and Gross Margin Turns Positive

Concord Healthcare Group Co., Ltd. has announced an extraordinary general meeting on April 10, 2026, in Beijing to seek shareholder approval for a comprehensive credit line and related guarantees for 2026. This move aims to enhance financing flexibility to support the company's operations and growth initiatives. The latest analyst rating for Concord Healthcare (HK:2453) is a Sell, with a price target of HK$1.50. The company operates in the Chinese healthcare market and is listed in Hong Kong.

Concord Healthcare Calls April EGM to Approve 2026 Credit Line and Guarantees

CONCORD HC GP announced that its Guangzhou Hospital Proton Center has officially been in operation for one year. All four proton therapy rooms have been fully utilized, providing proton therapy services to a total of 550 patients, with more than 80 new patients added each month. In July 2025, the Guangzhou Hospital Proton Center completed the country's first proton treatment for ocular choroidal malignant melanoma

CONCORD HC GP Guangzhou Hospital Proton Center added over 80 new proton therapy patients in a single month

According to a report from Economic Information Agency on the 5th, CONCORD HC GP announced that Shanghai Medical Star has pledged shares with Zhongcheng as the beneficiary to secure a loan financing of up to RMB 500 million. Yesterday, the controlling shareholder Beijing Taihecheng additionally pledged 35.6023 million H shares held by it with Zhongcheng as the beneficiary. The group stated that the H shares pledged by Beijing Taihecheng account for approximately 4.54% of the total issued shares of the group. (wh)

etnet

CONCORD HC GP's major shareholder Beijing Taihe Cheng pledged 35.6 million H shares as additional collateral for a loan

According to the Zhitong Finance APP, CONCORD HC GP announced that on August 26, 2025, the company's controlling shareholder Beijing Taihe Cheng agreed to pledge 35.6 million H shares of the company with Shanghai Pudong Development Bank as the beneficiary. The company received a notice from Beijing Taihe Cheng on October 27, 2025, that the pledge had been fully released on October 27, 2025. As of the date of this announcement, Beijing Taihe Cheng holds 35.6023 million H shares of the company, accounting for approximately 4.54% of the company's issued shares

Zhitong

CONCORD HC GP received the release of the pledge of 35.6 million shares by its controlling shareholder Beijing Taihe Cheng

CONCORD HC GP has reached a financing cooperation with Beijing Daxing Development Financial Leasing Co., Ltd., with a financing amount not exceeding 20 million RMB, a term of three years, and an interest rate of 4.19%. This move will expand CONCORD HC GP's financing channels, enrich funding sources, support future business development, and promote long-term cooperation with professional institutions in the industry

CONCORD HC GP has reached a financing cooperation with Dongxing Development Leasing

CONCORD HC GP rebounded over 5%. The stock was officially removed from the Hong Kong Stock Connect starting September 8, and its price has cumulatively dropped over 30% in the past four trading days. As of the time of publication, it rose 5.57% to HKD 3.22, with a trading volume of HKD 7.7041 million. In terms of news, CONCORD HC GP announced this morning that it was informed by its controlling shareholder Concord Medical Services Holdings Limited (CCM) that CCM plans to increase its stake in the company within 12 months from the date of this announcement. The company has been informed that to facilitate the increase, CCM will use its own funds through its subsidiaries to purchase shares in the open market, and specific transactions will be disclosed in a timely manner according to regulations. The announcement stated that the increase plan aims to consolidate CCM's controlling position, raise CCM's shareholding ratio, and convey a positive message to the market that the controlling shareholder is confident in the group's future prospects and long-term development

Understanding the Market | CONCORD HC GP rebounds over 5%, stock price drops by 30% in the past 4 days, controlling shareholder plans to increase company equity

CONCORD HC GP(02453.HK)

Concord Healthcare Completes HK$68 Million Convertible Bond Issue Under General Mandate

Concord Healthcare to Raise HK$68 Million via Convertible Bonds for Debt Repayment and Working Capital

"Performance" CONCORD HC GP's annual loss narrowed to 257 million RMB

Concord Healthcare Narrows Losses as Revenue Climbs and Gross Margin Turns Positive

Concord Healthcare Calls April EGM to Approve 2026 Credit Line and Guarantees

CONCORD HC GP Guangzhou Hospital Proton Center added over 80 new proton therapy patients in a single month

CONCORD HC GP's major shareholder Beijing Taihe Cheng pledged 35.6 million H shares as additional collateral for a loan

CONCORD HC GP received the release of the pledge of 35.6 million shares by its controlling shareholder Beijing Taihe Cheng

CONCORD HC GP has reached a financing cooperation with Dongxing Development Leasing

Understanding the Market | CONCORD HC GP rebounds over 5%, stock price drops by 30% in the past 4 days, controlling shareholder plans to increase company equity